share_log

Taro Pharmaceutical Industries | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SUN PHARMACEUTICAL INDUSTRIES LTD.(78.48%),DILIP S. SHANGHVI(78.48%), etc.

Taro Pharmaceutical Industries | SC 13D/A:超过5%持股股东披露文件(修正)-SUN PHARMACEUTICAL INDUSTRIES LTD.(78.48%),DILIP S. SHANGHVI(78.48%)等

美股sec公告 ·  2022/09/08 14:54
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息